Evaluation of Target Organs Impairment on Patients Suffering From High Blood Pressure

Completed

• Conditions: Blood Pressure

• Registration Number: NCT00925470
• Lead Sponsor: AstraZeneca

Brief Summary

Evaluation of target organs impairment on patients suffering from high blood pressure without known cardio vascular or renal disease, stratified on blood pressure control.

Detailed Description

Not available

Study Timeline

• Study Start: 2009-06
• Study First Submitted: 2009-06-19
• Study First Submitted QC: 2009-06-19
• Study First Posted: 2009-06-22
• Status Verified: 2009-12
• Study Completion: 2009-12
• Last Update Submitted: 2009-12-17
• Last Update Posted: 2009-12-18

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 1200

Inclusion Criteria

• Adults with hypertension (treated or not), without known cardiovascular or renal disease.

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To evaluate the frequency of evaluation of target organs preclinical impairment on patients without known cardiovascular or renal disease, taking into consideration the blood pressure level (controlled HBP or not)	Once

Trial Locations

Locations (1)

Research Site; 🇫🇷 Yvetot, France